INmune Bio, Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms. The DN-TNF product platform utilizes dominant-negative technology to selectively neutralize soluble TNF, a key driver of innate immune dysfunction and mechanistic target of many […]

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”) a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of Eduardo Molinari, a former executive of Abbott Laboratories (NYSE: ABT) (“Abbott”) and AbbVie Ltd. (NYSE: ABBV) (“AbbVie”) as Chief Marketing Officer. Mr. Molinari will […]

The Latest “Behind the Buzz” Show: Featuring Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 10A) COO Camilo Villalba Blueberries Medical Corp. is seeking to become a large-scale producer of naturally grown premium-quality cannabis with its primary operations well situated in the Bogota savanna in central Colombia. Lead by a specialized team with proprietary expertise […]

The Children’s Tumor Foundation (CTF) is a foundation dedicated to improving the health and well-being of individuals and families affected by neurofibromatosis (NF). The Foundation is the largest private funder of NF research and works to create the best forms of treatment for sufferers of NF. Annette Bakker, the Children’s Tumor Foundation’s President and Chief […]